AbbVie will acquire Stemcentrx and its lead late-stage asset rovalpituzumab tesirine (Rova-T), a novel biomarker-specific therapy derived from cancer stem cells.

The company voluntarily recalls product due to particulate matter.

The company’s preservative-free multidose eyedropper wins award.

The company announced the launch of its first-in-class Lynx CDR connectors at INTERPHEX 2016.

The VeriPac UBV Leak Detection System is designed specifically for multi-cavity blister packs.

The ink has a fast dry time, making it suitable for pharmaceutical packaging and labeling.

The agency publishes draft guidance on assay development and validation for immunogenicity testing.

WHO report highlights goal of eliminating malaria in 35 countries by 2030.

Beckman Coulter Life Science’s new Vi-Cell Metaflex is designed to be operational for more than 22 hours a day.

Plasticell was recognized for its contribution to the advancement of regenerative medicine, cell and gene therapy, as well as other areas of biomedical research.

The Subcommittee for Advanced Manufacturing of the National Science and Technology Council highlights biopharmaceutical manufacturing as an emerging priority.

Asking the right questions is crucial to establishing a biopharmaceutical facility design.

Pfizer announced the launch of Pfizer CentreOne, a CMO formed by the combination of Pfizer CentreSource and Hospira One 2 One.

BÜCHI Rotavapor R-300 received the German Design Awards 2016, the RedDot Award 21, and the iF International Forum Design Award.

The National Institutes of Health (NIH) released a statement on April 19, 2016 saying that it plans to suspend research in two laboratories after preliminary results found the labs not in compliance with CGMP practices.

Traditional methods of measuring the effectiveness of vaccines against the flu are called into question by new findings from the NIH.

Extract Technology’s portfolio will now include aseptic solutions, containment solutions, restricted access barriers, and mobile cleanrooms for the pharmaceutical, healthcare, biotech and chemical markets.

The guidance discusses the implementation of CMC postapproval changes through a comparability protocol.

PRAC said it has plans to review both canagliflozin and several direct-acting antivirals, after new study data showed potential risks associated with the drugs.

Sanofi will invest in its Geel, Belgium facility in order to support its pipeline of monoclonal antibodies.

The facility located in Ware, UK, will be used to manufacture GSK’s Ellipta inhaler.

Shire announces plans to build a flexible biopharmaceutical manufacturing facility in County Meath, Ireland.

Through two acquisitions, Recipharm will acquire Kemwell’s United States, Swedish, and Indian operations.

The new affiliate company will be based in Somerset, New Jersey.

The agency published guidance on data integrity as it is relates to CGMP compliance.

Linker technology and drug combinations play an important role in the efficacy of ADCs.

The National Institute of Health will conduct an internal review of the National Cancer Institute’s cell manufacturing facilities, which will affect multiple Kite projects.

FDA explains the rewards that may be associated with switching from batch to continuous manufacturing.